Pediatric Paracorporeal and Extracorporeal Therapies (PPET) Summit 2021
2021 年儿科体外和体外治疗 (PPET) 峰会
基本信息
- 批准号:10156359
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-07 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Liver FailureAcute Renal Failure with Renal Papillary NecrosisAddressAdultAdult Respiratory Distress SyndromeAlbuminsAmericanAreaBlood Component RemovalCaregiversCaringChildChild CareChild SupportChildhoodChildhood InjuryClinicalCollaborationsCommunitiesComplexConsensusCritical CareCritical IllnessCritically ill childrenDataDevicesDialysis procedureDrug KineticsEducationEducational workshopEthicsEvidence based practiceExtracorporeal Membrane OxygenationFaceFailureFamilyFosteringFutureGoalsGuidelinesHeart-Lung TransplantationHomeHospitalsHybridsIndividualInstitutionInternationalKnowledgeLearningLifeLiverMapsMedical Care TeamMedical DeviceMedicineModalityMultiple Organ FailureNational Institute of Child Health and Human DevelopmentOrganOrgan failureOutcomePatient CarePatientsPediatric Intensive Care UnitsPersonsPhysiologicalPlasmapheresisPublicationsQuality of CareRecoveryRenal Replacement TherapyResearchResourcesResuscitationRoleSeriesShapesSocietiesStandardizationStructureTechnologyTerminologyTimeTransplantationVariantWorkadvanced systembasebody systemclinical careexpectationexperienceimprovedimproved outcomeinnovationmedical specialtiesmeetingsmultimodalitynovelpediatric patientsprospectivesymposiumventricular assist devicevirtualworking group
项目摘要
Project Summary
Pediatric paracorporeal and extracorporeal therapies (PPET) are increasingly applied to support
children with multiple organ failure (MOF). These highly complex, resource intensive technologies
lie at the interface of innovation and the highest complexity clinical care; in patients with MOF,
multiple treatment modalities are frequently used simultaneously. However, lack of clinical
guidelines or consensus statements to guide PPET use result in a lack of standardization of
practice, compounded by limited dialogue between experts and institutions regarding PPET use,
in particular in the application of multiple PPET modalities. Children are further disenfranchised
due to the lack of medical devices optimized for the varied size and physiological differences in
pediatric practice. There is a critical need for collaborative initiatives aimed at standardization of
practice, quality improvement, research and innovation as they relate to the applications of PPET.
The PPET Summit 2021 will transform these critical gaps into knowledge and research
opportunities by bringing together, for the first time, pediatric and adult experts from across the
globe in the fields of extracorporeal membrane oxygenation, ventricular assist device, renal
replacement therapy, extracorporeal liver support, and apheresis. The Summit will bring together
local and international experts to define the current status of PPET, including the role of hybrid
and tandem therapies; standardize current approaches; identify key knowledge gaps that need to
be addressed to facilitate optimal patient care, and set a collaborative research and quality
agenda to improve our understanding of PPET. This will provide an exciting and much needed
framework to optimize the care of these patients and improve their outcomes.
Preconference working groups, led by experts selected by the diverse organizing committee
around the core domains ((1) patient and family experiences and outcomes; (2) pharmacokinetics;
(3) standardization of terminology and quality metrics; (4) innovation; (5) ethics; (6) circuit and
organ interactions and cross-talk) will work in a series of highly structured virtual workshops to
maximize global participation in the months prior to the Summit to generate consensus
statements. The Summit itself will include state of-the-art presentations from the experts to define
the current status, underlining the importance of cross-pollination of multiple therapies and
approaches. On the final day, a session entitled `Map the Future' will bring together summaries
from the pre-conference workshops with all attendees to refine research imperatives for PPET
initiatives, including discussion of potential future summits. The proceedings of the first PPET
Summit will be disseminated as a series of leading articles in Critical Care and Resuscitation.
项目概要
儿科体外和体外治疗 (PPET) 越来越多地应用于支持
患有多器官衰竭(MOF)的儿童。这些高度复杂、资源密集型的技术
处于创新和最复杂的临床护理的交汇处; MOF 患者,
多种治疗方式经常同时使用。但临床缺乏
指导 PPET 使用的指南或共识声明导致缺乏标准化
实践,再加上专家和机构之间关于 PPET 使用的有限对话,
特别是在多种 PPET 模式的应用中。儿童的权利被进一步剥夺
由于缺乏针对不同尺寸和生理差异进行优化的医疗设备
儿科实践。迫切需要旨在标准化的协作举措
与 PPET 应用相关的实践、质量改进、研究和创新。
2021 年 PPET 峰会将把这些关键差距转化为知识和研究
首次汇集来自世界各地的儿科和成人专家
体外膜氧合、心室辅助装置、肾功能领域的全球
替代疗法、体外肝脏支持和血浆分离术。此次峰会将汇聚
本地和国际专家定义 PPET 的现状,包括混合动力的作用
和串联疗法;标准化当前方法;确定需要的关键知识差距
旨在促进最佳的患者护理,并建立协作研究和质量
议程以提高我们对 PPET 的理解。这将提供一个令人兴奋且急需的
框架来优化这些患者的护理并改善他们的结果。
会前工作组,由不同组委会选出的专家领导
围绕核心领域((1) 患者和家属的经历和结果;(2) 药代动力学;
(3) 术语和质量指标的标准化; (4)创新; (五)道德规范; (6)电路和
器官相互作用和串扰)将在一系列高度结构化的虚拟研讨会中进行
在峰会前几个月最大限度地提高全球参与度以达成共识
声明。峰会本身将包括专家们的最先进的演讲,以定义
当前的状况,强调了多种疗法异花授粉的重要性,
接近。最后一天,题为“绘制未来”的会议将汇总总结
来自与所有与会者的会前研讨会,以完善 PPET 的研究必要性
倡议,包括讨论未来可能举行的峰会。首届 PPET 会议进程
峰会将作为重症监护和复苏领域的一系列领先文章进行传播。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cefepime Dosing in a Critically Ill Neonate Receiving Continuous Renal Replacement Therapy With the Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM).
使用心肾小儿透析急救机 (CARPEDIEM) 接受连续肾脏替代治疗的危重新生儿的头孢吡肟剂量。
- DOI:10.5863/1551-6776-28.2.167
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Toy,Cynthia;Stimes,Grant;Moore,Megan;Srivaths,Poyyapakkam;Arikan,AyseAkcan
- 通讯作者:Arikan,AyseAkcan
Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system.
使用 Carpediem™ 系统进行新生儿连续肾脏替代治疗的清除和营养。
- DOI:10.1007/s00467-023-06237-w
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Vuong,KimT;Vega,MollyR;Casey,Lauren;Swartz,SarahJ;Srivaths,Poyyapakkam;Osborne,ScottW;Rhee,ChristopherJ;Arikan,AyseAkcan;Joseph,Catherine
- 通讯作者:Joseph,Catherine
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ayse Akcan Arikan其他文献
Ayse Akcan Arikan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ayse Akcan Arikan', 18)}}的其他基金
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10670228 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10667491 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10248814 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10468845 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10393794 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Collaborative Pediatric Critical Care Research Network - Clinical Site
儿科重症监护协作研究网络 - 临床网站
- 批准号:
10470941 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
- 批准号:
MR/V038583/1 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Research Grant
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10421290 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
- 批准号:
21K08685 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10180251 - 财政年份:2021
- 资助金额:
$ 7.5万 - 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
- 批准号:
20K21607 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
- 批准号:
MR/T044802/1 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
- 批准号:
19K08475 - 财政年份:2019
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
- 批准号:
9789253 - 财政年份:2018
- 资助金额:
$ 7.5万 - 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
- 批准号:
18K08662 - 财政年份:2018
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




